This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Irvin S Y Chen: Innovator in HTLV-II Detection Methods
Introduction
Irvin S Y Chen is a notable inventor based in Woodland Hills, CA. He has made significant contributions to the field of virology, particularly in the detection of human T-cell lymphotropic virus type II (HTLV-II). His innovative work has implications for both medical research and clinical diagnostics.
Latest Patents
Irvin S Y Chen holds a patent for "Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides." This invention relates to a novel HTLV-II isolate designated NRA, which was originally isolated from a patient with atypical hairy cell leukemia. The patent details methods and kits for detecting HTLV-II antibodies using specific envelope proteins encoded by the env gene, particularly the gp46 and p21 proteins.
Career Highlights
Chen's career is marked by his association with Abbott Laboratories Corporation, where he has contributed to advancements in medical diagnostics. His work has been pivotal in enhancing the understanding and detection of HTLV-II, a virus that poses significant health risks.
Collaborations
Irvin S Y Chen has collaborated with notable colleagues, including Helen H Lee and Priscilla Swanson. These partnerships have fostered a collaborative environment that promotes innovation and research in virology.
Conclusion
Irvin S Y Chen's contributions to the detection of HTLV-II antibodies represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile